ESC Premium Access

Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study

Congress Presentation

About the speakers

Doctor Francesco Bruno

Hospital Molinette of the University Hospital S. Giovanni Battista, Turin (Italy)
0 follower

Doctor Florian Wenzl

University of Zurich, Zurich (Switzerland)
3 presentations
0 follower

7 more presentations in this session

Temporal trends in major bleeding after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction from 2003 to 2017: the Western Denmark Heart Registry

Speaker: Doctor P. Thrane (Aarhus, DK)

Thumbnail

Thirty days clinical outcomes following stent implantation with aspirin-free prasugrel monotherapy in non-ST segment elevation myocardial infarction. Interim report from ASET-Japan pilot study

Speaker: Doctor K. Miyashita (Galway, IE)

Thumbnail

Ticagrelor vs. clopidogrel in ST elevation myocardial infarction patients with hemoglobin > 160

Speaker: Doctor T. Gu (Tianjin, CN)

Thumbnail

Association of P2Y12 inhibitor pretreatment strategy with short and long term ischemic and bleeding outcomes in NSTE-ACS patients

Speaker: Doctor K. Keskin (Istanbul, TR) Associate Professor A. Calik (Istanbul, TR)

Thumbnail

Differential prognostic significance of platelet reactivity based on ischemic risk after percutaneous coronary intervention

Speaker: Assistant Professor K. Jeon (Seongnam, KR)

Thumbnail

Access the full session

Bleeding and antiplatelet strategies in acute coronary syndromes

Speakers: Doctor F. Bruno, Doctor F. Wenzl, Doctor P. Thrane, Doctor K. Miyashita, Doctor T. Gu...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations